Work

Phase II Trial Of The BRAF Inhibitor, Vemurafenib, In Patients With BRAF Mutant Relapsed Or Refractory Hairy Cell Leukemia

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.2876.2876

Authors: Jae H Park, Stephen S. Chung, Young Rock Chung, Helen Won, Julie Teruya-Feldstein, Michael Berger, Talal T Khawaja, Mario E Lacouture, Ross L. Levine, Omar Abdel-Wahab, Martin S Tallman

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W255967453

FWCI: 0.891

Cites:

Cited by: 7

Related to: 10